Studylib
Explore Categories
Login
Upload document Create flashcards
Login
Flashcards Collections
Documents
Last activity
My documents
Saved documents
Profile
Add to collection(s) Add to saved
  1. Vetenskap
  2. Health Science
  3. Psykiatri

Nya rökavvänjningspreparat olämpliga vid psykisk

advertisement
advertisement
Is the category for this document correct?
  1. Vetenskap
  2. Health Science
  3. Psykiatri
Thank you for your participation!
Related documents
Tobaksberoende – Läkemedelsboken 2014
Tobaksberoende – Läkemedelsboken 2014
Tobak och cancer
Tobak och cancer
Nikotinberoende - Stiftelsen Choice
Nikotinberoende - Stiftelsen Choice
SOD farmaka Reynisdottir [Read-Only
SOD farmaka Reynisdottir [Read-Only
Läkemedel för tobaksavvänjning
Läkemedel för tobaksavvänjning
Klinisk betydelse?
Klinisk betydelse?
Tentamen - IDA.LiU.se - Linköpings universitet
Tentamen - IDA.LiU.se - Linköpings universitet
Vol 1.Depr.sl - kopia.indd
Vol 1.Depr.sl - kopia.indd
Naltrexon + bupropion (Mysimba)
Naltrexon + bupropion (Mysimba)
Betydelsen av neurodegenerativa processer vid bipolär sjukdom
Betydelsen av neurodegenerativa processer vid bipolär sjukdom
Orsaker till psykiska funktionsnedsättningar
Orsaker till psykiska funktionsnedsättningar
Bupropion Sandoz modified-release tablet PL
Bupropion Sandoz modified-release tablet PL
Download
advertisement
Add this document to collection(s)

You can add this document to your study collection(s)

Sign in Available only to authorized users
Add this document to saved

You can add this document to your saved list

Sign in Available only to authorized users
Products
Documents Flashcards
Support
Report Partners
© 2013 - 2026 studylibsv.com all other trademarks and copyrights are the property of their respective owners
Privacy Terms

Make a suggestion

Did you find mistakes in interface or texts? Or do you know how to improve StudyLib UI? Feel free to send suggestions. It's very important for us!

 

Suggest us how to improve StudyLib

(For complaints, use another form )

Input it if you want to receive answer

Rate us